Pharmacodynamic Modeling of Risk Factors for Ciprofloxacin Resistance in <i>Pseudomonas aeruginosa</i>

Abstract

Application of pharmacokinetic and pharmacodynamic principles to dosing of ciprofloxacin may reduce the risk of ciprofloxacin resistance to the level seen in isolates exposed to other agents.